drugset / Trial / NCT00515801
Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM
RandomizedCrossoverSingle-blindPrevention
Summary
We aim to demonstrate that oral administration of glibenclamide stimulates pancreatic glucagon secretion during hypoglycemia in insulin-deficient (C-peptide negative) patients with type 1 diabetes when compared to type 1 diabetic patients with residual insulin secretion (C-peptide positive).
Timeline
- Start
- 2007-06
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glyburide | Small molecule | 15 mg | Oral |